SmartKem, Inc.
SMTK Nasdaq Semiconductors & Related Devices Financials FY2020βFY2025
What SmartKem, Inc. does
No business description yet.
- Legal name
- SmartKem, Inc.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K Β· Apr 8, 2026
- Accession Β· CIK
- 0001104659-26-040562
0001817760
Revenue and margins
SmartKem, Inc. had $0.7M of revenue in fiscal 2025, up 750.0% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was β$7.9M in fiscal 2025, β1,127.5% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
SmartKem, Inc. returned β to shareholders in fiscal 2025. The diluted share count rose 150.2%.
Balance sheet
Cash, debt and the ratios that show how comfortably SmartKem, Inc. can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $12.2M | $4.2M | $8.8M | $7.1M | $0.4M |
| Interest coverage | β858.0x | β | β | β | β |
| Current ratio | 9.3x | 4.6x | 6.0x | 3.7x | 0.3x |
| Quick ratio | 9.3x | 4.6x | 6.0x | 3.7x | 0.3x |
| Total assets | $15.1M | $7.5M | $11.3M | $8.9M | $2.3M |
| Total liabilities | $1.5M | $1.6M | $3.2M | $2.3M | $6.2M |
| Shareholders' equity | $13.5M | $5.9M | $8.1M | $6.6M | β$3.9M |
| Net debt (β = net cash) | β | β | β | β | β |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β | β |
| F-score | β / 3 | 4 / 8 | 3 / 8 | 3 / 8 | 3 / 8 | 2 / 8 |
| Accruals ratio | β646.0% | β82.2% | β21.7% | β4.9% | β22.1% | β49.6% |
| Altman Z'' | β70.55 | β8.81 | β38.01 | β25.66 | β42.29 | β229.29 |
6 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|
| Income statement | ||||||
| Revenue | $0.1M | $0.0M | $0.0M | $0.0M | $0.1M | $0.7M |
| Gross profit | $0.0M | $0.0M | $0.0M | $0.0M | $0.1M | $0.4M |
| Research and development | $4.3M | $8.2M | $5.8M | $5.6M | $5.1M | $7.0M |
| Operating income | β$4.6M | β$16.3M | β$9.7M | β$10.0M | β$10.5M | β$12.8M |
| Interest expense | $6.8M | $0.0M | β | β | β | β |
| Pretax income | β$23.1M | β$17.1M | β$11.5M | β$8.5M | β$10.3M | β$10.5M |
| Income tax | β | β | $0.0M | β | $0.0M | β$0.0M |
| Net income | β$23.1M | β$17.1M | β$11.5M | β$8.5M | β$10.3M | β$10.5M |
| Net income to common | β | β | β | β$8.5M | β$19.6M | β$10.5M |
| Diluted EPS | β$1.80 | β$0.68 | β$13.88 | β$6.32 | β$6.00 | β$1.29 |
| Diluted shares | 0.01B | 0.03B | 0.00B | 0.00B | 0.00B | 0.01B |
| Cash flow | ||||||
| Cash from operations | β$4.1M | β$9.7M | β$9.0M | β$8.0M | β$8.1M | β$7.7M |
| Capital expenditure | $0.1M | $0.3M | $0.1M | $0.0M | $0.1M | $0.1M |
| Free cash flow | β$4.2M | β$10.1M | β$9.1M | β$8.1M | β$8.2M | β$7.9M |
| Depreciation and amortization | $0.2M | $0.2M | $0.2M | $0.1M | $0.3M | $0.2M |
| Stock-based compensation | β | $6.2M | $0.5M | $0.7M | $0.9M | $1.0M |
| Balance sheet | ||||||
| Cash and short-term investments | $0.8M | $12.2M | $4.2M | $8.8M | $7.1M | $0.4M |
| Total debt | $0.2M | β | β | β | β | β |
| Finance lease liabilities | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Current assets | $2.0M | $14.1M | $6.4M | $10.5M | $8.5M | $1.5M |
| Current liabilities | $1.1M | $1.5M | $1.4M | $1.8M | $2.3M | $5.9M |
| Property and equipment, net | $0.7M | $0.8M | $0.6M | $0.5M | $0.3M | $0.2M |
| Total assets | $2.9M | $15.1M | $7.5M | $11.3M | $8.9M | $2.3M |
| Total liabilities | $1.1M | $1.5M | $1.6M | $3.2M | $2.3M | $6.2M |
| Shareholders' equity | $1.9M | $13.5M | $5.9M | $8.1M | $6.6M | β$3.9M |
| Margins | ||||||
| Gross margin | 41.5% | 55.6% | 17.5% | 14.8% | 61.0% | 61.0% |
| Operating margin | β4,840.4% | β90,566.7% | β24,235.0% | β37,003.7% | β12,761.0% | β1,841.5% |
| EBITDA margin | β4,630.9% | β89,405.6% | β23,740.0% | β36,466.7% | β12,446.3% | β1,811.0% |
| Net margin | β24,609.6% | β95,144.4% | β28,737.5% | β31,477.8% | β12,597.6% | β1,507.7% |
| FCF margin | β4,468.1% | β55,938.9% | β22,820.0% | β29,833.3% | β9,964.6% | β1,127.5% |
| Returns | ||||||
| Return on capital | β271.3% | β | β | β | β | β |
| Return on capital employed | β243.2% | β120.3% | β158.3% | β105.1% | β158.2% | 354.4% |
| Return on equity | β1,249.8% | β222.8% | β118.5% | β121.4% | β140.5% | β791.0% |
| Return on assets | β784.4% | β190.2% | β101.8% | β90.4% | β102.4% | β187.8% |
| Return on tangible equity | β1,249.8% | β126.7% | β195.4% | β104.8% | β296.7% | β |
| Growth | ||||||
| Revenue growth | β | β80.9% | 122.2% | β32.5% | 203.7% | 750.0% |
| Share count change | β | 96.8% | β96.7% | 62.4% | 142.4% | 150.2% |
| Financial health | ||||||
| Debt / equity | 0.1x | β | β | β | β | β |
| Interest coverage | β0.7x | β858.0x | β | β | β | β |
| Current ratio | 1.9x | 9.3x | 4.6x | 6.0x | 3.7x | 0.3x |
| Quick ratio | 1.9x | 9.3x | 4.6x | 6.0x | 3.7x | 0.3x |
| Capital allocation | ||||||
| Capex / revenue | 125.5% | 1,894.4% | 197.5% | 66.7% | 91.5% | 17.6% |
| Stock comp / revenue | β | 34,422.2% | 1,220.0% | 2,655.6% | 1,036.6% | 149.2% |
| Quality scores | ||||||
| Piotroski F-score | β | 4.0 | 3.0 | 3.0 | 3.0 | 2.0 |
| Altman Z'' | β70.6 | β8.8 | β38.0 | β25.7 | β42.3 | β229.3 |
| Accruals ratio | β646.0% | β82.2% | β21.7% | β4.9% | β22.1% | β49.6% |
Source: SEC EDGAR XBRL filings (CIK 0001817760). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.